… In conclusion, for patients with advanced lung adenocarcinoma, the use of first-line EGFR-TKIs
in patients who harbored the EGFR 19 del might be associated with higher ORR and …

… (EGFR) gene in lung adenocarcinoma are associated with a dramatic clinical response to
EGFR-tyrosine kinase inhibitors (TKIs… a relapse after treatment with EGFR-TKIs, even when the …

… We identified 137 patients in whom EGFR-mutant metastatic lung adenocarcinoma
developed and who were treated with gefitinib or erlotinib within the study period. Table 1 …

… growth factor receptor (EGFR)‑tyrosine kinase inhibitors (TKIs) is a … EGFR‑mutated non‑small
cell lung cancer (NSCLC), and substantially improves their prognosis. However, EGFR …

… Lung cancer is a leading cause of cancer-related death worldwide, with non–small-cell lung
cancer (NSCLC) accounting for 80–85% of all lung … growth factor receptor (EGFR) gene are …

… As has been described, EGFR-TKIs are not universally effective for lung cancer, but these …
Asian, nonsmoking female patients with adenocarcinomas with EGFR mutations. The different …

… in the EGFR mutation status in paired samples of primary pulmonary adenocarcinoma and
… Our results may help to explain the phenomenon of mixed tumor responses to EGFR TKIs …

… EGFR) gene in lung adenocarcinoma are associated with a dramatic clinical response to
EGFR tyrosine kinase inhibitor (TKI… initial response to treatment with EGFR-TKI in such patients, …

… with lung adenocarcinoma that transformed to SCLC after acquired resistance to EGFR TKI
… -old female non-smoker with lung adenocarcinoma that transformed to SCLC 2 years after …

… factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) – … with EGFR mutation-positive
non-small cell lung cancer (NSCLC). Given the long-term exposure of such patients to EGFR-TKIs, …